medrxiv Subject Collection: Pain Medicine Palliative Medicine
http://medrxiv.org
This feed contains articles for medRxiv Subject Collection "Pain Medicine Palliative Medicine"
medrxivmedrxivhttps://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png
http://medrxiv.org
<![CDATA[
Beyond intensity: Pain distribution shapes healthcare- and treatment-seeking beliefs in individuals with and without clinical pain
]]>
https://www.medrxiv.org/content/10.64898/2026.04.02.26349577v1?rss=1
2026-04-04doi:10.64898/2026.04.02.26349577Cold Spring Harbor Laboratory2026-04-04
<![CDATA[
PainWaive: A Consumer-grade Digitally Delivered EEG Neurofeedback Intervention for Chronic Low Back Pain
]]>
https://www.medrxiv.org/content/10.64898/2026.03.26.26349247v1?rss=1
2026-04-01doi:10.64898/2026.03.26.26349247Cold Spring Harbor Laboratory2026-04-01
<![CDATA[
Association of Suzetrigine With Postoperative Outcomes Versus Opioid Analgesics: Propensity-Matched Study
]]>
https://www.medrxiv.org/content/10.64898/2026.03.29.26349666v1?rss=1
Age 18 years) who underwent surgery and received suzetrigine were compared with patients who underwent surgery and received opioids. Propensity score matching (1:1) performed to match cohorts based on demographic factors (age, gender, racial/ethnic status), social determinants of health (ICD-10 Z55-Z65), family histories of substance abuse and psychiatric disorders (Z81.x), surrogate measures of prior healthcare utilization, and pre-existing clinical severity using Elixhauser-Charlson comorbidity proxies (hypertensive diseases [I10-I15], diabetes mellitus [E08-E13], ischemic heart disease [I22-I25], and chronic pulmonary disease [J42-J47]). Matching also included behavioral risk factors (tobacco use and physical inactivity) and body mass index (BMI). Following matching, there were 2,221 patients in each cohort. The primary outcome assessed within one year after surgery was ED utilization, depression, anxiety, post-traumatic stress disorder (PTSD) and sleep disorders. Risk estimates and survival analyses were used to compare the outcomes.
ResultsIn propensity-matched analyses, suzetrigine use was associated with a reduction in multiple psychiatric outcomes and healthcare utilization compared to opioid analgesics. There was less ED utilization in the suzetrigine cohort (5.9% v 13.1%, RR 0.45, p< .001). The psychiatric outcomes were also lower in the suzetrigine cohort than the opioid cohort, including depression (3.1% v 4.7%, RR 0.65, p= .005), anxiety (4.7% v 7.2%, RR 0.65, p< .001), PTSD (0.5% v 1.4%, RR 0.36, p= .002), and sleep disorders (4.2% v 6.0%, RR 0.71, p= .008). The survival analysis suggested an earlier onset of psychiatric diagnosis among the opioid recipients.
ConclusionIn a matched real-world cohort of surgical patients, suzetrigine use was associated with lower short-term rates of selected postoperative outcomes compared with opioid analgesics.
]]>2026-03-31doi:10.64898/2026.03.29.26349666Cold Spring Harbor Laboratory2026-03-31
<![CDATA[
Dementia and End-of-Life Shared Decision-Making Among Older US Adults
]]>
https://www.medrxiv.org/content/10.64898/2026.03.27.26349555v1?rss=1
2026-03-30doi:10.64898/2026.03.27.26349555Cold Spring Harbor Laboratory2026-03-30
<![CDATA[
Pulsed Electromagnetic Fields in Chronic Pain Management: a KDM6B-Mediated Modulation Mechanism Hypothesis
]]>
https://www.medrxiv.org/content/10.64898/2026.03.23.26348899v1?rss=1
2026-03-25doi:10.64898/2026.03.23.26348899Cold Spring Harbor Laboratory2026-03-25
<![CDATA[
Structural and Functional Alterations of the Dorsolateral Prefrontal Cortex Across Chronic Pain Cohorts
]]>
https://www.medrxiv.org/content/10.64898/2026.03.24.26349122v1?rss=1
2026-03-25doi:10.64898/2026.03.24.26349122Cold Spring Harbor Laboratory2026-03-25
<![CDATA[
Working memory in chronic pain: evidence for task-specific rather than global differences
]]>
https://www.medrxiv.org/content/10.64898/2026.03.20.26348805v1?rss=1
2026-03-25doi:10.64898/2026.03.20.26348805Cold Spring Harbor Laboratory2026-03-25
<![CDATA[
Meta-analytic Evidence for Four Amplifier Loops in Chronic Pain Chronification: Development of the Pain Amplifier Loop Framework (PALF) Risk Score
]]>
https://www.medrxiv.org/content/10.64898/2026.03.22.26348998v1?rss=1
500,000 participants) were included. Pooled odds ratios were: sleep disturbance OR=1.80 (95% CI 1.65-1.96; k=16; I2=51%), pain catastrophizing OR=2.11 (95% CI 1.71-2.61; k=8; I2=0%), metabolic/fat mass OR=2.02 (95% CI 1.32-3.09; k=7), preoperative opioid use OR=4.48 (95% CI 2.87-6.97; k=6; I2=84%), and opioid-benzodiazepine co-prescription OR=2.62 (95% CI 1.76-3.89; k=7; I2=79%). All four loops converge on TLR4/NF-{kappa}B microglial signaling. The PALF model produces a Systemic Load Score (Z) and probability of interventional failure P=1/(1+e-Z), enabling stratification into low (<0.30), moderate (0.30-0.60), and high ([≥]0.60) risk categories.
ConclusionsFour amplifier loops independently and substantially increase chronic pain risk, with the iatrogenic/opioid loop showing the largest effect. The PALF provides a transparent, clinically actionable risk score requiring prospective validation.
]]>2026-03-24doi:10.64898/2026.03.22.26348998Cold Spring Harbor Laboratory2026-03-24
<![CDATA[
Subjective and Objective Cognitive Functioning in Chronic Pain: Distinct Associations with Multidimensional Symptom Burden and Resting-State EEG
]]>
https://www.medrxiv.org/content/10.64898/2026.03.19.26348793v1?rss=1
2026-03-22doi:10.64898/2026.03.19.26348793Cold Spring Harbor Laboratory2026-03-22
<![CDATA[
Ecological Momentary Assessments of daily pain experiences in bothersome and high-impact chronic pain
]]>
https://www.medrxiv.org/content/10.64898/2026.03.18.26348727v1?rss=1
2026-03-20doi:10.64898/2026.03.18.26348727Cold Spring Harbor Laboratory2026-03-20
<![CDATA[
Identification of LPO and RTN4R as Proteomic Signatures of Pain Persistence: An Exploratory Analysis of the UK Biobank
]]>
https://www.medrxiv.org/content/10.64898/2026.03.17.26348624v1?rss=1
2026-03-19doi:10.64898/2026.03.17.26348624Cold Spring Harbor Laboratory2026-03-19
<![CDATA[
Efficacy of tDCS and EEG Neurofeedback, individually and combined, on Neuropathic Pain following spinal cord injury: Protocol for a Randomised Controlled Trial
]]>
https://www.medrxiv.org/content/10.64898/2026.03.11.26347999v1?rss=1
2026-03-18doi:10.64898/2026.03.11.26347999Cold Spring Harbor Laboratory2026-03-18
<![CDATA[
Palliative Care in Humanitarian Settings: An International Survey on Perceived Importance and Readiness among Health Emergency Response Unit Delegates
]]>
https://www.medrxiv.org/content/10.64898/2026.03.12.26348178v1?rss=1
2026-03-13doi:10.64898/2026.03.12.26348178Cold Spring Harbor Laboratory2026-03-13
<![CDATA[
Initiation of buprenorphine as part of pain management approach to trauma patients in the intensive care unit with a history of opioid use disorder: A QI Study
]]>
https://www.medrxiv.org/content/10.64898/2026.03.06.26347723v1?rss=1
2026-03-09doi:10.64898/2026.03.06.26347723Cold Spring Harbor Laboratory2026-03-09
<![CDATA[
Exploring Electroencephalography for Chronic Pain Biomarkers: A Large-Scale Benchmark of Data- and Hypothesis-Driven Models
]]>
https://www.medrxiv.org/content/10.64898/2026.03.06.26347785v1?rss=1
2026-03-06doi:10.64898/2026.03.06.26347785Cold Spring Harbor Laboratory2026-03-06
<![CDATA[
Personalizing neuromodulation for chronic pain: A connectivity-guided trial
]]>
https://www.medrxiv.org/content/10.64898/2026.03.02.26347430v1?rss=1
0.05). In prespecified exploratory analyses, we examined whether pre-therapy local connectivity (within-target wPLI) predicted treatment response. In the Classic-M1 group, lower pre-therapy local M1 connectivity was associated with a greater reduction in pain intensity (r = 0.50, p = 0.005). This association was not observed in the Low- or High-Connectivity groups. A regression model including group-by-connectivity interaction indicated that the relationship between local connectivity and pain reduction differed between the Classic-M1 and High-Connectivity groups (p = 0.038). The results of this clinical trial showed that connectivity-based target allocation using global connectivity did not improve clinical outcomes. However, lower local M1 connectivity was associated with greater pain reduction following Classic-M1 stimulation, suggesting that local M1 connectivity may serve as a potential biomarker of response.
]]>2026-03-04doi:10.64898/2026.03.02.26347430Cold Spring Harbor Laboratory2026-03-04
<![CDATA[
Real-world Opioid-Sparring Effects of Infiltration between the Popliteal Artery and the Capsule of the Knee (IPACK) in Patients Undergoing Anterior Cruciate Ligament Reconstruction
]]>
https://www.medrxiv.org/content/10.64898/2026.02.25.26346957v1?rss=1
2026-03-02doi:10.64898/2026.02.25.26346957Cold Spring Harbor Laboratory2026-03-02
<![CDATA[
Spinal Cord Stimulation for Persistent Spinal Pain Syndrome Type II: A Systematic Review and Subgroup Meta-analysis of Randomized Controlled Trials
]]>
https://www.medrxiv.org/content/10.64898/2026.02.20.26346691v1?rss=1
2026-02-26doi:10.64898/2026.02.20.26346691Cold Spring Harbor Laboratory2026-02-26
<![CDATA[
Study protocol for microneurographic investigation of nociceptor sensitisation in Fibromyalgia Syndrome. (MICRO-FMS)
]]>
https://www.medrxiv.org/content/10.64898/2026.02.24.26346973v1?rss=1
2026-02-26doi:10.64898/2026.02.24.26346973Cold Spring Harbor Laboratory2026-02-26
<![CDATA[
Peak alpha frequency is associated with pain severity in Long COVID patients with new-onset chronic pain
]]>
https://www.medrxiv.org/content/10.64898/2026.02.16.26346388v1?rss=1
2026-02-17doi:10.64898/2026.02.16.26346388Cold Spring Harbor Laboratory2026-02-17
<![CDATA[
Evaluation of a Cook Islands Maori model of palliative care: a protocol
]]>
https://www.medrxiv.org/content/10.64898/2026.02.11.26346011v1?rss=1
2026-02-14doi:10.64898/2026.02.11.26346011Cold Spring Harbor Laboratory2026-02-14
<![CDATA[
Development of a network for interactions and associations among biopsychosocial features of chronic low back pain
]]>
https://www.medrxiv.org/content/10.64898/2026.02.09.26345929v1?rss=1
2026-02-11doi:10.64898/2026.02.09.26345929Cold Spring Harbor Laboratory2026-02-11
<![CDATA[
PALLIATIVE CARE INTEGRATED INTO PRIMARY HEALTHCARE SERVICE (PALLI PHC) : AN IMPLEMENTATION STUDY IN ROHINGYA REFUGEE SETTING IN COXS BAZAR, BANGLADESH
]]>
https://www.medrxiv.org/content/10.64898/2026.02.03.26345518v1?rss=1
2026-02-05doi:10.64898/2026.02.03.26345518Cold Spring Harbor Laboratory2026-02-05
<![CDATA[
Using electronic health record data accessed via OpenSAFELY to develop indicators of end-of-life care quality
]]>
https://www.medrxiv.org/content/10.64898/2026.02.03.26345473v1?rss=1
2026-02-04doi:10.64898/2026.02.03.26345473Cold Spring Harbor Laboratory2026-02-04
<![CDATA[
Fatigue Links Sociodemographic Risk to Pain Intensity and Spread in Two Surgical Cohorts
]]>
https://www.medrxiv.org/content/10.64898/2026.02.02.26345387v1?rss=1
2026-02-04doi:10.64898/2026.02.02.26345387Cold Spring Harbor Laboratory2026-02-04
<![CDATA[
Developing Evidence-Based Criteria for Oxycodone Prescribing in Emergency Departments: A Protocol for the OxyGuidED Study Using the RAND/UCLA Appropriateness Method
]]>
https://www.medrxiv.org/content/10.64898/2026.02.01.26345327v1?rss=1
2026-02-03doi:10.64898/2026.02.01.26345327Cold Spring Harbor Laboratory2026-02-03
<![CDATA[
How does palliative care fit into national health spending? A secondary analysis of trends in long-term healthcare expenditure in the United Kingdom
]]>
https://www.medrxiv.org/content/10.64898/2026.01.23.26344608v1?rss=1
2026-01-24doi:10.64898/2026.01.23.26344608Cold Spring Harbor Laboratory2026-01-24
<![CDATA[
Astrocytes in neuropathic pain: Mechanistic and global insights
]]>
https://www.medrxiv.org/content/10.64898/2026.01.23.26344689v1?rss=1
2026-01-24doi:10.64898/2026.01.23.26344689Cold Spring Harbor Laboratory2026-01-24
<![CDATA[
Linking Data-Driven Symptom Dimensions to Resting-State EEG Biomarker Candidates in Chronic Pain
]]>
https://www.medrxiv.org/content/10.64898/2026.01.23.26344711v1?rss=1
2026-01-24doi:10.64898/2026.01.23.26344711Cold Spring Harbor Laboratory2026-01-24
<![CDATA[
Chronic pain: transdiagnostic meta-analytic evidence of convergent network signature with PTSD
]]>
https://www.medrxiv.org/content/10.64898/2026.01.21.26344503v1?rss=1
2026-01-22doi:10.64898/2026.01.21.26344503Cold Spring Harbor Laboratory2026-01-22